These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 34102100)

  • 1. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8
    Xu S; Chaudhary O; Rodríguez-Morales P; Sun X; Chen D; Zappasodi R; Xu Z; Pinto AFM; Williams A; Schulze I; Farsakoglu Y; Varanasi SK; Low JS; Tang W; Wang H; McDonald B; Tripple V; Downes M; Evans RM; Abumrad NA; Merghoub T; Wolchok JD; Shokhirev MN; Ho PC; Witztum JL; Emu B; Cui G; Kaech SM
    Immunity; 2021 Jul; 54(7):1561-1577.e7. PubMed ID: 34102100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD36-mediated ferroptosis dampens intratumoral CD8
    Ma X; Xiao L; Liu L; Ye L; Su P; Bi E; Wang Q; Yang M; Qian J; Yi Q
    Cell Metab; 2021 May; 33(5):1001-1012.e5. PubMed ID: 33691090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endophilin-A2-mediated increase in scavenger receptor expression contributes to macrophage-derived foam cell formation.
    Huang EW; Liu CZ; Liang SJ; Zhang Z; Lv XF; Liu J; Zhou JG; Tang YB; Guan YY
    Atherosclerosis; 2016 Nov; 254():133-141. PubMed ID: 27741419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.
    Han J; Hajjar DP; Febbraio M; Nicholson AC
    J Biol Chem; 1997 Aug; 272(34):21654-9. PubMed ID: 9261189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.
    Podrez EA; Poliakov E; Shen Z; Zhang R; Deng Y; Sun M; Finton PJ; Shan L; Febbraio M; Hajjar DP; Silverstein RL; Hoff HF; Salomon RG; Hazen SL
    J Biol Chem; 2002 Oct; 277(41):38517-23. PubMed ID: 12145296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner.
    Bao Y; Wang L; Xu Y; Yang Y; Wang L; Si S; Cho S; Hong B
    Atherosclerosis; 2012 Jul; 223(1):152-9. PubMed ID: 22658257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.
    Kunjathoor VV; Febbraio M; Podrez EA; Moore KJ; Andersson L; Koehn S; Rhee JS; Silverstein R; Hoff HF; Freeman MW
    J Biol Chem; 2002 Dec; 277(51):49982-8. PubMed ID: 12376530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor.
    Podrez EA; Hoppe G; O'Neil J; Hoff HF
    Free Radic Biol Med; 2003 Feb; 34(3):356-64. PubMed ID: 12543251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific oxidized phospholipids inhibit scavenger receptor bi-mediated selective uptake of cholesteryl esters.
    Ashraf MZ; Kar NS; Chen X; Choi J; Salomon RG; Febbraio M; Podrez EA
    J Biol Chem; 2008 Apr; 283(16):10408-14. PubMed ID: 18285332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipids for CD8
    Wu D; Chen Y
    Front Immunol; 2022; 13():1020422. PubMed ID: 36275711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36.
    Guy RA; Maguire GF; Crandall I; Connelly PW; Kain KC
    Atherosclerosis; 2001 Mar; 155(1):19-28. PubMed ID: 11223422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein.
    Boullier A; Gillotte KL; Hörkkö S; Green SR; Friedman P; Dennis EA; Witztum JL; Steinberg D; Quehenberger O
    J Biol Chem; 2000 Mar; 275(13):9163-9. PubMed ID: 10734051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating CD36
    Ao YQ; Gao J; Zhang LX; Deng J; Wang S; Lin M; Wang HK; Ding JY; Jiang JH
    BMC Cancer; 2023 Apr; 23(1):367. PubMed ID: 37085798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of lipid droplets in peripheral immune cells shows an immunomodulatory effect on monocyte polarization in experimental dyslipidaemia.
    Hung YP; Chen CL; Tseng PC; Satria RD; Chen MC; Lin CF
    Biochem Biophys Res Commun; 2023 Apr; 650():73-80. PubMed ID: 36773342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scavenger receptors and oxidized low density lipoproteins.
    Dhaliwal BS; Steinbrecher UP
    Clin Chim Acta; 1999 Aug; 286(1-2):191-205. PubMed ID: 10511292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α
    Kanaoka Y; Koga M; Sugiyama K; Ohishi K; Kataoka Y; Yamauchi A
    Toxicology; 2017 Apr; 380():62-71. PubMed ID: 28202387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of type 2 diabetes on CD36 expression and the uptake of oxLDL: Diabetes affects CD36 and oxLDL uptake.
    Kanoke A; Nishijima Y; Ljungberg M; Omodaka S; Yang SY; Wong S; Rabiller G; Tominaga T; Hsieh CL; Liu J
    Exp Neurol; 2020 Dec; 334():113461. PubMed ID: 32926860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36.
    Crucet M; Wüst SJ; Spielmann P; Lüscher TF; Wenger RH; Matter CM
    Atherosclerosis; 2013 Jul; 229(1):110-7. PubMed ID: 23706521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1.
    Zeng Y; Tao N; Chung KN; Heuser JE; Lublin DM
    J Biol Chem; 2003 Nov; 278(46):45931-6. PubMed ID: 12947091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation.
    Hsu YW; Hsu FF; Chiang MT; Tsai DL; Li FA; Angata T; Crocker PR; Chau LY
    J Biomed Sci; 2021 Jan; 28(1):5. PubMed ID: 33397354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.